Agilent Technologies

Agilent Technologies

Yahoo Finance • 4 hours ago

Microarray Analysis - Global Strategic Business Report 2026: Secure Share in a $5.1 Billion Market by 2032, Featuring Profiles of Key Players Agilent, Illumina, Roche and Thermo Fisher

Company Logo Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Microarray Analysis - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global microarray analysis market was valued at US$3.3 billion... Full story

Yahoo Finance • 6 hours ago

Glycomics / Glycobiology - Global Strategic Business Report 2026: Capitalize on a $4.5 Billion Market by 2032 | Agilent, Bruker, Danaher, Merck, and Thermo Fisher Battle for Share

Company Logo Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Glycomics / Glycobiology - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global glycomics / glycobiology market was valued at US$1.... Full story

Yahoo Finance • 6 hours ago

Agilent Completes Acquisition of Proscia

Expands Agilent's pathology portfolio and establishes a platform for scientific intelligence in tissue-based precision medicine Strengthens Agilent's ability to support customers across clinical diagnostics, biopharma and life-sciences re... Full story

Yahoo Finance • yesterday

3D Cell Culture - Global Strategic Business Report: Capitalize on 13.9% CAGR to US$3.9 Billion by 2030 as Agilent, Corning, GE Healthcare and Bio-Rad Reshape Drug Discovery

Company Logo Boost drug development ROI with scalable 3D cultures that improve screening accuracy, reduce animal testing and late-stage failures, and enable personalized medicine. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "3D Cell Cultur... Full story

Yahoo Finance • yesterday

Metabolomics - Global Strategic Business Report: Capitalize on an 11.7% CAGR to Secure the $7.1 Billion 2030 Market as Thermo Fisher, Agilent, Bruker, Waters, and Metabolon Reshape Competition

Company Logo Precision medicine, biomarker and drug discovery, multi-omics, AI analytics, and rising pharma investment are accelerating metabolomics adoption. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Metabolomics - Global Strategic Bus... Full story

Yahoo Finance • yesterday

Commercial Biotechnology Separation Systems - Global Strategic Business Report: Capture the $6.5B Surge by 2032 as 3M, Agilent, Merck KGaA, and Sartorius Disrupt Bioprocessing

Company Logo Boost ROI through AI-enabled separation, advanced chromatography, emerging-market expansion and new applications that improve purity, yields and operational efficiency. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Commercial B... Full story

Yahoo Finance • 5 days ago

Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche

Company Logo Profiles Roche Diagnostics, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies and Silence Therapeutics, covering their RNAi technology market activities. Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Ribonucleic Acid (... Full story

Yahoo Finance • 5 days ago

Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and Illumina

Company Logo Players: Thermo Fisher, Labcorp, Quest Diagnostics, Eurofins, Agilent. Profiles cover fetal aneuploidy tests, technologies, applications and end users. Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Aneuploidy Confirmation... Full story

Yahoo Finance • 6 days ago

Is Agilent Technologies (A) Fully Valued Following Its University Of Chicago Energy Storage Partnership?

Agilent Technologies (A) has partnered with the University of Chicago to establish a new Center of Excellence for Energy Materials Research, placing its analytical instruments at the center of next generation battery and grid storage work.... Full story

Yahoo Finance • 6 days ago

AI in Pathology Market Size, Share, Trends, and Global Forecast 2026-2036 | A $1.72 Billion Opportunity Featuring Profiles of Key Players Leica Biosystems (Danaher), Roche, Hamamatsu Photonics, Fujifilm, Agilent Technologies

Company Logo Boost ROI by targeting services, computer vision, drug discovery, diagnostic labs and Asia-Pacific, supported by cloud integration and strategic partnerships Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "AI in Pathology Market... Full story

Yahoo Finance • 6 days ago

Long Oligo Pool Synthesis for Capture Global Market Report 2026 | Capitalize on $3.31B by 2030 as Twist Bioscience, Agilent, Eurofins and BGI Scale AI-Driven Precision Oncology

Company Logo Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Long Oligo Pool Synthesis for Capture Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global long oligo pool synthesis for capture market is expe... Full story

Yahoo Finance • 6 days ago

Global Bead-Linked Transposase Library Kits Market Report 2026 | Capitalize on 11.6% CAGR Through 2030 as Illumina, Thermo Fisher, Roche, and Agilent Scale AI-Automated Sequencing

Company Logo Profiles Roche, Thermo Fisher, Eurofins, Agilent and Illumina, covering bead-linked transposase kits for streamlined DNA/RNA sequencing-library preparation Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Bead-Linked Transposase L... Full story

Yahoo Finance • 6 days ago

Molecular Spectroscopy - Global Strategic Business Report: Capitalize on the Surge to $8.7 Billion by 2032 as Agilent, Bruker, Danaher, and Thermo Fisher Scientific Accelerate AI-Driven Analysis

Company Logo Boost ROI by targeting pharma, portable and AI-enabled spectroscopy, rapid testing, regulatory compliance, and Asia-Pacific expansion. Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Molecular Spectroscopy - Global Strategic Busi... Full story

Yahoo Finance • 6 days ago

Global Pooled CRISPR Screening Market Report 2026 | Capitalize on 16.1% CAGR as Thermo Fisher, Merck, Danaher and Agilent Accelerate AI-Driven Multi-Omics Workflows

Company Logo Players: Thermo Fisher, Merck KGaA, Danaher, Agilent and QIAGEN. Profile covers CRISPR screening segments, trends, competition, regions and opportunities. Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Pooled Clustered Regularly... Full story

Yahoo Finance • 7 days ago

3 Reasons to avoid A and 1 stock to buy instead

3 Reasons to avoid A and 1 stock to buy instead What a fantastic six months it's been for Agilent. Shares of the company have skyrocketed 54.6%, hitting $177.58. This was partly due to its solid quarterly results, and the run-up might hav... Full story

Yahoo Finance • 8 days ago

BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount?

Is BIO a good stock to buy? We came across a bullish thesis on Bio-Rad Laboratories, Inc. on One Idea Per Day's Substack by Paul. The thesis was published on July 21st, when the stock was trading at $281.11, and BIO has gained 32.48% since... Full story

Yahoo Finance • 8 days ago

Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research

Agilent CoE supports research on next-generation energy storage materials SANTA CLARA, Calif. & CHICAGO, October 27, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technol... Full story

Yahoo Finance • 15 days ago

Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry

Company Logo Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Bioconjugation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is experiencing rapid growth, supported by expanding biologi... Full story

Yahoo Finance • 15 days ago

Dogness loses Nasdaq's minimum bid price requirement compliance

* Dogness (International) (DOGZ [https://seekingalpha.com/symbol/DOGZ]) said on Tuesday that it is not in compliance with the minimum bid price requirement of the Nasdaq market. * This notification has no immediate effect on the listin... Full story

Yahoo Finance • 21 days ago

PharmaCorp RX appoints new CFO

* PharmaCorp RX (PCRX:CA [https://seekingalpha.com/symbol/PCRX:CA]) announced [https://seekingalpha.com/pr/20685266-pharmacorp-announces-cfo-transition-and-appointment-of-andrew-hodson-as-chief-financial] that Andrew Hodson will become c... Full story